Identification and Therapeutic Intervention of Coactivated Anaplastic Lymphoma Kinase, Fibroblast Growth Factor Receptor 2, and Ephrin Type‐A Receptor 5 Kinases in Hepatocellular Carcinoma

Though kinase inhibitors have been heavily investigated in the clinic to combat advanced hepatocellular carcinoma (HCC), clinical outcomes have been disappointing overall, which may be due to the absence of kinase‐addicted subsets in HCC patients. Recently, strategies that simultaneously inhibit mul...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Xin, Zhang, Minmin, Ping, Fangfang, Liu, Hongchun, Sun, Jingya, Wang, Yueqin, Shen, Aijun, Ding, Jian, Geng, Meiyu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6586030/
https://www.ncbi.nlm.nih.gov/pubmed/29356025
http://dx.doi.org/10.1002/hep.29792

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6586030/
https://www.ncbi.nlm.nih.gov/pubmed/29356025
http://dx.doi.org/10.1002/hep.29792

Ejemplares similares